TR200002437T2 - B grubu streptococcus antijenleri. - Google Patents

B grubu streptococcus antijenleri.

Info

Publication number
TR200002437T2
TR200002437T2 TR2000/02437T TR200002437T TR200002437T2 TR 200002437 T2 TR200002437 T2 TR 200002437T2 TR 2000/02437 T TR2000/02437 T TR 2000/02437T TR 200002437 T TR200002437 T TR 200002437T TR 200002437 T2 TR200002437 T2 TR 200002437T2
Authority
TR
Turkey
Prior art keywords
group
streptococcus antigens
antigens
streptococcus
gbs
Prior art date
Application number
TR2000/02437T
Other languages
English (en)
Inventor
R. Brodeur Bernard
Rioux Clement
Boyer Martine
Charlebois Isabelle
Hamel Josee
Martin Denis
Original Assignee
Biochem Pharma Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochem Pharma Inc. filed Critical Biochem Pharma Inc.
Publication of TR200002437T2 publication Critical patent/TR200002437T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Bu bulus antijenler, özellikle de terapi ve/veya profilaksi için asi komponentleri olarak faydali olan B grubu streptokok (GBS) bakteriyel patojenlerin protein antijenleri ile ilgilidir.
TR2000/02437T 1998-02-20 1999-02-17 B grubu streptococcus antijenleri. TR200002437T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7542598P 1998-02-20 1998-02-20

Publications (1)

Publication Number Publication Date
TR200002437T2 true TR200002437T2 (tr) 2000-11-21

Family

ID=22125658

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02437T TR200002437T2 (tr) 1998-02-20 1999-02-17 B grubu streptococcus antijenleri.

Country Status (22)

Country Link
US (4) US20030031682A1 (tr)
EP (3) EP2280072B1 (tr)
JP (2) JP4637350B2 (tr)
KR (1) KR100771148B1 (tr)
CN (2) CN1944652A (tr)
AP (1) AP2000001886A0 (tr)
AT (1) ATE347600T1 (tr)
AU (1) AU2505999A (tr)
CA (1) CA2321106C (tr)
CZ (1) CZ301056B6 (tr)
DE (1) DE69934299T2 (tr)
EA (1) EA200000860A1 (tr)
ES (2) ES2540281T3 (tr)
HU (1) HU228497B1 (tr)
ID (1) ID27482A (tr)
IL (3) IL137921A0 (tr)
NO (2) NO330491B1 (tr)
NZ (1) NZ529854A (tr)
OA (1) OA11686A (tr)
TR (1) TR200002437T2 (tr)
WO (1) WO1999042588A2 (tr)
ZA (1) ZA991325B (tr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU228497B1 (en) 1998-02-20 2013-03-28 Id Biomedical Corp Quebec Group b steptococcus antigens
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
WO2000006736A2 (en) * 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
GB0105922D0 (en) * 2001-03-09 2001-04-25 Microscience Ltd Genes and proteins, and their use
SI1141308T1 (sl) 1998-12-22 2007-08-31 Microscience Ltd Streptokokni proteini skupine B in njihova uporaba
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
US6833356B1 (en) 1999-08-25 2004-12-21 Medimmune, Inc. Pneumococcal protein homologs and fragments for vaccines
CA2382795A1 (en) * 1999-08-25 2001-03-01 Medimmune, Inc. Homologs of a pneumococcal protein and fragments for vaccines
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
EP1294771B1 (en) 2000-06-12 2008-10-29 University Of Saskatchewan Chimeric GapC protein from Streptococcus and its use in vaccination and diagnosis
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
CA2411927C (en) * 2000-06-12 2012-08-07 University Of Saskatchewan Immunization of dairy cattle with gapc protein against streptococcus infection
EP1734050A3 (en) * 2000-06-12 2012-12-05 University Of Saskatchewan Immunization of dairy cattle with GapC protein against streptococcus infection
JP4102186B2 (ja) 2000-10-13 2008-06-18 アイディー バイオメディカル コーポレイション グループｂストレプトコッカスのｂｖｈ−ａ２及びｂｖｈ−ａ３抗原
EP2189473A3 (en) 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nucleic and proteins from streptococcus groups A & B
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
EP1472353B1 (en) * 2002-02-11 2012-02-01 ID Biomedical Corporation Group b streptococcus antigen
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
CA2532369C (en) 2003-07-31 2016-07-26 Chiron Corporation Immunogenic compositions for streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US20060165716A1 (en) 2004-07-29 2006-07-27 Telford John L Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
CA2583803C (en) 2004-10-08 2014-11-25 Giuliano Bensi Immunogenic and therapeutic compositions for streptococcus pyogenes
CA2597170A1 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biological S North America Pharmaceutical compositions
GB0605247D0 (en) * 2006-03-15 2006-04-26 Chiron Srl Compositions and methods for immunisation
US8287885B2 (en) 2007-09-12 2012-10-16 Novartis Ag GAS57 mutant antigens and GAS57 antibodies
WO2009081274A2 (en) 2007-12-21 2009-07-02 Novartis Ag Mutant forms of streptolysin o
CN102304185A (zh) * 2011-09-02 2012-01-04 黑龙江八一农垦大学 预防奶牛乳房炎的融合蛋白sip-trap及制备方法和应用
EP2949340A1 (en) * 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US5302386A (en) 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5679768A (en) 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5225331A (en) 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
HU217582B (hu) 1993-03-19 2000-02-28 Gunnar Lindahl Streptococcus B csoportba tartozó törzsek elleni immunitást biztosító, Rib fehérjenevű felületi protein, eljárás a protein tisztítására, reagenskészlet és gyógyszerkészítmény
US5595740A (en) 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
EP0754703A4 (en) * 1994-11-01 1999-11-24 Kirin Brewery PEPTIDE SEQUENCE FORMING A MUCIN CHAIN AND TECHNIQUE FOR MODIFYING THE PROTEIN TO BE LINKED TO THE MUCIN CHAIN
WO1998018931A2 (en) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
HU228497B1 (en) 1998-02-20 2013-03-28 Id Biomedical Corp Quebec Group b steptococcus antigens
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
WO2000006736A2 (en) 1998-07-27 2000-02-10 Microbial Technics Limited Nucleic acids and proteins from group b streptococcus
EP2050464B1 (en) 1998-12-21 2019-08-07 Medimmune, Inc. Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
PT2261358E (pt) 1998-12-23 2014-07-30 Id Biomedical Corp Quebec Antigénios de streptococcus
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
EP1472353B1 (en) 2002-02-11 2012-02-01 ID Biomedical Corporation Group b streptococcus antigen

Also Published As

Publication number Publication date
JP2002507396A (ja) 2002-03-12
CA2321106A1 (en) 1999-08-26
US20110182923A1 (en) 2011-07-28
IL190018A (en) 2011-07-31
US7914794B2 (en) 2011-03-29
ATE347600T1 (de) 2006-12-15
IL137921A (en) 2008-06-05
CN1268745C (zh) 2006-08-09
KR100771148B1 (ko) 2007-10-29
HU228497B1 (en) 2013-03-28
ID27482A (id) 2001-04-12
ZA991325B (en) 1999-08-20
HUP0102304A1 (hu) 2001-10-28
US8226953B2 (en) 2012-07-24
US20030228323A1 (en) 2003-12-11
CZ301056B6 (cs) 2009-10-29
EP1054971B1 (en) 2006-12-06
OA11686A (en) 2005-01-12
HUP0102304A3 (en) 2008-03-28
NO20101682L (no) 2000-10-19
CN1944652A (zh) 2007-04-11
EP2280072A2 (en) 2011-02-02
ES2278436T3 (es) 2007-08-01
NO20004161D0 (no) 2000-08-18
NO330491B1 (no) 2011-05-02
JP4637350B2 (ja) 2011-02-23
DE69934299T2 (de) 2007-07-05
CZ20003054A3 (cs) 2001-03-14
DE69934299D1 (de) 2007-01-18
WO1999042588A2 (en) 1999-08-26
AP2000001886A0 (en) 2000-09-30
CA2321106C (en) 2013-07-23
US20130095498A1 (en) 2013-04-18
EP1054971A2 (en) 2000-11-29
IL137921A0 (en) 2001-10-31
AU2505999A (en) 1999-09-06
US8580262B2 (en) 2013-11-12
IL190018A0 (en) 2008-08-07
CN1297482A (zh) 2001-05-30
KR20010034518A (ko) 2001-04-25
EP2280072B1 (en) 2015-03-25
EP1757697A3 (en) 2007-05-30
EP2280072A3 (en) 2012-06-06
NO20004161L (no) 2000-10-19
NZ529854A (en) 2005-08-26
US20030031682A1 (en) 2003-02-13
JP2009242403A (ja) 2009-10-22
ES2540281T3 (es) 2015-07-09
WO1999042588A3 (en) 2000-03-23
EA200000860A1 (ru) 2001-10-22
EP1757697A2 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
TR200002437T2 (tr) B grubu streptococcus antijenleri.
TR200200633T2 (tr) Yeni streptococcus antijenleri
MXPA03000103A (es) Antigenos de streptococcus.
IL110829A0 (en) Hybrid toxin fragments and toxins comprising them
TR200201484T2 (tr) Çeşitli hastalıkların koruyucu ve iyileştirici tedavisi için bakteriyel fajlar ile ilişkili lisleme enzimlerinin kullanımı
MXPA03009294A (es) Proteinas de superficie de streptococcus pyogenes.
HUP9902457A2 (hu) Pneumococcus felületi fehérjéket tartalmazó oltóanyag-készítmények
BE2021C506I2 (tr)
AU7227001A (en) Streptococcus pyogenes antigens
ATE362481T1 (de) Lantibiotikum
ES2196539T3 (es) Facilitacion de la cicatrizacion con la toxina cm101/gbs.
SE9600434D0 (sv) Recombinant phages
WO2003068813A3 (en) Group b streptococcus antigen
EP1451338B8 (en) Recombinant antibodies for the detection and neutralization of anthrax toxin
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
MY122001A (en) Reducing agent for reductive alkylation of glycopeptide antibiotics
ATE547527T1 (de) Gruppe b streptococcus bvh-a2 und bvh-a3 antigene
WO2002088178A8 (en) Antigens of group b streptococcus and corresponding dna fragments
EP1950302A3 (en) Streptococcus antigens